{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:53:09Z","timestamp":1790974389141,"version":"4.1.0"},"reference-count":33,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Classification of acute leukemia involves assigning lineage by resemblance of blasts to normal progenitor cells. This approach provides descriptive information that is useful for disease monitoring, provides clues to pathogenesis, and can help to select effective chemotherapeutic regimens. Acute leukemias of ambiguous lineage (ALAL) are those leukemias that either fail to show evidence of myeloid, B-lymphoid, or T-lymphoid lineage commitment or show evidence of commitment to more than 1 lineage, including mixed-phenotype acute leukemia (MPAL). The different treatment regimens for acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) make ALAL a challenge both diagnostically and therapeutically. Current classification criteria have reduced the reported incidence of mixed lineage leukemias by emphasizing fewer markers and categorizing some biphenotypic leukemias with recurrent cytogenetic abnormalities as other entities. Several recent studies have explored the genomic and epigenetic landscape of MPAL and emphasize the genomic heterogeneity of MPAL. Two classification proposals of myeloid malignancies recently been published and include International Consensus Classification and fifth edition of the World Health Organization Classification of Haematolymphoid Tumours. Our review aims to discuss the diagnostic challenges in the setting of classification updates, recent genomic studies, and therapeutic strategies in this poorly understood disease.<\/jats:p>","DOI":"10.1182\/hematology.2024000554","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T15:03:05Z","timestamp":1733497385000},"page":"287-292","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":18,"title":["How to think about acute leukemia of ambiguous lineage"],"prefix":"10.1182","volume":"2024","author":[{"given":"Olga K.","family":"Weinberg","sequence":"first","affiliation":[{"name":"UT Southwestern Medical Center, BioCenter, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"issue":"11","key":"2024121115401287800_hem2024000554C1","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1038\/leu.2010.202","article-title":"Mixed-phenotype acute leukemia: historical overview and a new definition","volume":"24","author":"Weinberg","year":"2010","journal-title":"Leukemia"},{"issue":"1","key":"2024121115401287800_hem2024000554C2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/ajcp\/aqac070","article-title":"How I diagnose acute leukemia of ambiguous lineage","volume":"158","author":"Weinberg","year":"2022","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"2024121115401287800_hem2024000554C3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MOH.0000000000000322","article-title":"Mixed-phenotype acute leukemia: current challenges in diagnosis and therapy","volume":"24","author":"Wolach","year":"2017","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"2024121115401287800_hem2024000554C4","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.path.2019.03.008","article-title":"Acute leukemias of ambiguous lineage: clarification on lineage specificity","volume":"12","author":"Kurzer","year":"2019","journal-title":"Surg Pathol Clin"},{"key":"2024121115401287800_hem2024000554C5","doi-asserted-by":"crossref","first-page":"106301","DOI":"10.1016\/j.leukres.2020.106301","article-title":"Acute undifferentiated leukemia: data on incidence and outcomes from a large population-based database","volume":"89","author":"Qasrawi","year":"2020","journal-title":"Leuk Res"},{"issue":"18","key":"2024121115401287800_hem2024000554C6","first-page":"2275","article-title":"The International Consensus Classification of acute leukemias of ambiguous lineage","volume":"141","author":"Weinberg","year":"2023","journal-title":"Blood"},{"issue":"7","key":"2024121115401287800_hem2024000554C7","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/s41375-018-0058-4","article-title":"Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis","volume":"32","author":"Maruffi","year":"2018","journal-title":"Leukemia"},{"key":"2024121115401287800_hem2024000554C8","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001"},{"key":"2024121115401287800_hem2024000554C9","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"issue":"20","key":"2024121115401287800_hem2024000554C10","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"11","key":"2024121115401287800_hem2024000554C11","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"7","key":"2024121115401287800_hem2024000554C12","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"3","key":"2024121115401287800_hem2024000554C13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1182\/blood-2017-12-821363","article-title":"International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia","volume":"132","author":"Hrusak","year":"2018","journal-title":"Blood"},{"issue":"6","key":"2024121115401287800_hem2024000554C14","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/ajh.25771","article-title":"Diagnostic workup of acute leukemias of ambiguous lineage","volume":"95","author":"Patel","year":"2020","journal-title":"Am J Hematol"},{"issue":"1","key":"2024121115401287800_hem2024000554C15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1309\/HDUE-DN2E-B72E-JK99","article-title":"Myeloperoxidase immunoreactivity in adult acute lymphoblastic leukemia","volume":"116","author":"Arber","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"2024121115401287800_hem2024000554C16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00428-022-03448-8","article-title":"International Consensus Classification of acute lymphoblastic leukemia\/lymphoma","volume":"482","author":"Duffield","year":"2023","journal-title":"Virchows Arch"},{"issue":"9","key":"2024121115401287800_hem2024000554C17","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s41379-019-0263-3","article-title":"Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group","volume":"32","author":"Weinberg","year":"2019","journal-title":"Mod Pathol"},{"issue":"3","key":"2024121115401287800_hem2024000554C18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cll.2021.03.016","article-title":"Update on acute leukemias of ambiguous lineage","volume":"41","author":"Aggarwal","year":"2021","journal-title":"Clin Lab Med"},{"issue":"7727","key":"2024121115401287800_hem2024000554C19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41586-018-0436-0","article-title":"The genetic basis and cell of origin of mixed phenotype acute leukaemia","volume":"562","author":"Alexander","year":"2018","journal-title":"Nature"},{"issue":"1","key":"2024121115401287800_hem2024000554C20","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1038\/s41467-018-04924-z","article-title":"Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes","volume":"9","author":"Takahashi","year":"2018","journal-title":"Nat Commun"},{"issue":"9","key":"2024121115401287800_hem2024000554C21","first-page":"773","article-title":"14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia","volume":"138","author":"Di Giacomo","year":"2021","journal-title":"Blood"},{"issue":"8","key":"2024121115401287800_hem2024000554C22","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.exphem.2016.05.003","article-title":"Mixed-phenotype acute leukemia (MPAL) exhibits frequent mutations in DNMT3A and activated signaling genes","volume":"44","author":"Eckstein","year":"2016","journal-title":"Exp Hematol"},{"issue":"23","key":"2024121115401287800_hem2024000554C23","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1182\/bloodadvances.2018023531","article-title":"PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation","volume":"2","author":"Xiao","year":"2018","journal-title":"Blood Adv"},{"issue":"11","key":"2024121115401287800_hem2024000554C24","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/ajh.25256","article-title":"Genomic and clinical characterization of B\/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations","volume":"93","author":"Mi","year":"2018","journal-title":"Am J Hematol"},{"issue":"10","key":"2024121115401287800_hem2024000554C25","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/ajh.27435","article-title":"Optical genome mapping improves the accuracy of classification, risk stratification, and personalized treatment strategies for patients with acute myeloid leukemia","volume":"99","author":"Loghavi","year":"2024","journal-title":"Am J Hematol"},{"key":"2024121115401287800_hem2024000554C26","doi-asserted-by":"crossref","first-page":"107309","DOI":"10.1016\/j.leukres.2023.107309","article-title":"Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: a study from the Bone Marrow Pathology Group","volume":"130","author":"Kirtek","year":"2023","journal-title":"Leuk Res"},{"issue":"9","key":"2024121115401287800_hem2024000554C27","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1182\/bloodadvances.2021006239","article-title":"TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS\/AML","volume":"6","author":"Weinberg","year":"2022","journal-title":"Blood Adv"},{"issue":"15","key":"2024121115401287800_hem2024000554C28","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1182\/blood.2021014472","article-title":"Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome","volume":"139","author":"Grob","year":"2022","journal-title":"Blood"},{"issue":"2","key":"2024121115401287800_hem2024000554C29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ajcp\/aqaa208","article-title":"Myeloid\/lymphoid neoplasms associated with eosinophilia and rearrangements of PDGFRA, PDGFRB, or FGFR1 or with PCM1-JAK2","volume":"155","author":"Pozdnyakova","year":"2021","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"2024121115401287800_hem2024000554C30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1309\/AJCPSTU55DRQEGTE","article-title":"Acute leukemias of ambiguous origin","volume":"144","author":"Porwit","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"2024121115401287800_hem2024000554C31","doi-asserted-by":"crossref","first-page":"105626","DOI":"10.1016\/j.humpath.2024.07.003","article-title":"Clinicopathologic features and outcomes of acute leukemia harboring PICALM::MLLT10 fusion","volume":"151","author":"Wang","year":"2024","journal-title":"Hum Pathol"},{"issue":"17","key":"2024121115401287800_hem2024000554C32","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa1815105","article-title":"Tagraxofusp in blastic plasmacytoid dendritic-cell neoplasm","volume":"380","author":"Pemmaraju","year":"2019","journal-title":"N Engl J Med"},{"issue":"10","key":"2024121115401287800_hem2024000554C33","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1182\/blood.2020008745","article-title":"Targeting the p-D-C: easy as C-D-1-2-3?","volume":"137","author":"Pemmaraju","year":"2021","journal-title":"Blood"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2024\/1\/287\/2346355\/287weinberg.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2024\/1\/287\/2346355\/287weinberg.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T20:00:00Z","timestamp":1733947200000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2024\/1\/287\/526182\/How-to-think-about-acute-leukemia-of-ambiguous"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12,6]]},"published-print":{"date-parts":[[2024,12,6]]}},"URL":"https:\/\/doi.org\/10.1182\/hematology.2024000554","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12,6]]},"published":{"date-parts":[[2024,12,6]]}}}